Music-visual Guided Physical Activity Promotion for Adults With Intellectual Disabilities
NCT ID: NCT04938999
Last Updated: 2022-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
320 participants
INTERVENTIONAL
2022-01-05
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Compared with usual care, MVgPA can significantly increase the participant's PA level and improve their PA self-efficacy and interest, and functional exercise capacity.
Design and participants: This cluster-randomized controlled trial will recruit 400 Chinese adults with mild to moderate ID from 20 residential care facilities.
Intervention: Based on the information-motivation-strategy model, MVgPA comprises a motivational and strategical preparatory session and ongoing support to residential service providers and a 12-week group-based staff-facilitated MVgPA (two 75-min session/week) for adults with ID. Outcome measurement PA level (primary outcome) will be measured by using an activity tracker. PA self-efficacy and interest will be measured by the Baseline Interview Questionnaire and visual analogue scale respectively. Functional exercise capacity will be measured by six-minute walk test. All outcomes will be measured at baseline, 13 and 25 weeks.
Data analysis: Intervention effects will be estimated using three-level mixed effects model.
Expected results: MVgPA will effectively enhance the PA levels of adults with ID. After intervention implementation, we expect that at least 50% of the residential care facilities allocated to the intervention group will demonstrate their willingness to continue to implement the MVgPA program (score 4 out of 6, 6 = most willing).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiometabolic Health Intervention Using Movement-to-Music Exercise
NCT05606432
Effectiveness-Implementation Cluster RCT to Improve Community-dwelling Early Dementia Patients by Music Intervention
NCT03575026
Music-with-Movement Intervention for People With Early Dementia and Their Families
NCT01976832
A Music-with-movement Exercise Program for Community-dwelling Older Adults Suffering From Chronic Pain: a Pilot Randomized Controlled Trial
NCT04696211
Improving Motor Skills: The Role of Music and Encouragement
NCT06380088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participant recruitment The person-in-charge of residential care facilities and the non-governmental organizations that serve adults with ID, including the Hong Chi Association who had collaborated with us in our pilot project, will be approached by the research team to seek their collaboration and support in recruiting participants and implementing the project. The research team will organize promotion talks and distribute promotion leaflets of the project to potential participants and their families or legal guardians. To ensure safety of the participants, PA pre-participation health screening will be performed in accordance with the guidelines of American College Sport Medicine. Medical clearance/approval to participate MVgPA will be sought if they have known cardiovascular, metabolic and/or renal disease, or signs and symptoms suggesting these diseases (as detailed in Appendix 1). An information sheet related to the MVgPA, including the heart rates during the PA and type of exercise, will be provided to the physicians.
Sample size calculation A similar study for adults with ID in community residences showed an effect size of 0.35 on PA level change. Assuming a similar effect size on PA level change in our proposed trial, a sample size of 129 participants per each of the control and intervention groups will provide the study with 80% power at 2-sided 5% level of significance, as estimated using the power analysis software PASS 13.0 (NCSS, Kaysville, USA). Furthermore, to account for potential reduction in statistical efficiency due to randomization by residential care facilities (clusters) instead of individual participants, a variance inflation factor, called design effect, will be applied to impose to the estimated sample size. The design effect is given by 1 + (m-1)\*ICC, where m=average cluster size and ICC=intracluster correlation coefficient of the underlying outcome. We anticipate that the outcomes of the participants recruited from the same residential care facility are unlikely correlated with one another, particularly for the PA outcome. In this regard, the ICC would be small. A synthesis study revealed that ICC tends to be small in primary care research with a median of 0.005 and inter-quartile range of 0.000 to 0.021. Allowing for a conservative ICC of 0.01 in our proposed study, at least 16 participants per each of the 20 residential care facility are therefore required. Furthermore, to allow up to 20% attrition rate, at least 20 participants per facility will be recruited.
Cluster randomization Randomization will be performed at the cluster level (residential care facility) instead of individual participants to avoid contamination between the intervention and control groups. The facilities will be randomized to either intervention or control group in a 1:1 ratio. Eligible participants recruited from the same facility will be allocated to either intervention or control groups accordingly. Group allocation will be concealed from outcome assessors and made according to the random group allocation sequence generated by an independent statistician and the sequence of entry into the study.
Data analysis By considering the potential design effect of the randomization conducted in cluster level instead of individual participants, the outcome analysis will be performed on the basis of a three-level mixed effects model accounting for inter-correlation among individuals within the same cluster as well as intra-correlation over time within an individual and variations between individuals. This type of model can account for intra-correlated clustered and repeated measures data and produce unbiased estimates even in the presence of missing data, provided that the data are missing at random. Mixed-effects model will be used to compare the differential changes in each outcome variables (PA level, PA self-efficacy and interest, and exercise capacity) across time (T0, T1, T2) between the two groups. Positive significant group-by-T1 and group-by-T2 interaction-terms in the mixed-effects models indicate significantly greater increment of intervention group in the underlying outcome than the control group at the respective time-points with respect to T0.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MVgPA group
The MVgPA group consists of 24 sessions conducted over 12 weeks for the study participants by the staff of residential care facilities.
The structured MVgPA group session (10 - 12 participants) will be conducted twice per week. The 75-min music-paced physical activities will be presented in the PowerPoint slideshow. The instructions for an upper limb exercise will be presented in a large number pad in the slideshow, and the participants will then be asked to follow the actions and directions presented on the slide.
Music-visual guided physical activity (MVgPA)
The MVgPA adopts the information-motivation-strategy model to address the personal and environmental challenges in PA initiation and maintenance of adults with intellectual disability.
To support the staff of residential care facilities in implementing 24 sessions of MVgPA in 12 weeks, the first six sessions will be led by the RA1 and co-facilitated by the staff, while the subsequent sessions will be conducted by the staff only. At week 6, another set of MVgPA will be implemented to increase the participant's interest; two sessions will be co-facilitated by RA1. At weeks 6 and 9, the RN and RA1 will hold a meeting with the staff of the residential care facilities to acknowledge the achievement of the staff and adults with ID, as well as to address any of their concerns related to the implementation of MVgPA, and to identify the facilitators and tackle barriers to the implementation of the MVgPA.
Control group
residential care facilities will conduct their usual activities during the study period. A trained RA2 will record the activities conducted by the residential care facilities during the study period.
Usual care
As control group, residential care facilities will conduct their usual activities during the study period. A trained RA will record the activities conducted by the residential care facilities during the study period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Music-visual guided physical activity (MVgPA)
The MVgPA adopts the information-motivation-strategy model to address the personal and environmental challenges in PA initiation and maintenance of adults with intellectual disability.
To support the staff of residential care facilities in implementing 24 sessions of MVgPA in 12 weeks, the first six sessions will be led by the RA1 and co-facilitated by the staff, while the subsequent sessions will be conducted by the staff only. At week 6, another set of MVgPA will be implemented to increase the participant's interest; two sessions will be co-facilitated by RA1. At weeks 6 and 9, the RN and RA1 will hold a meeting with the staff of the residential care facilities to acknowledge the achievement of the staff and adults with ID, as well as to address any of their concerns related to the implementation of MVgPA, and to identify the facilitators and tackle barriers to the implementation of the MVgPA.
Usual care
As control group, residential care facilities will conduct their usual activities during the study period. A trained RA will record the activities conducted by the residential care facilities during the study period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand basic information and instructions of the intervention and to make decisions upon their participation;
* Classified as physically inactive (i.e., \<150-min moderate-intensity or 75-min vigorous-intensity PA/week);
* Currently using residential service user as stated in the Social Welfare Department of Hong Kong SAR.
Exclusion Criteria
* Physically unable to participate in the MVgPA, such as having significant mobility problem;
* Participation to MVgPA will put them at physiological risk; or
* At risk of self-harm as determined by the staff of the residential care facilities.
18 Years
64 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Food and Health Bureau, Hong Kong
OTHER_GOV
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ho Yu CHENG
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Nethersole School of Nursing, Chinese University of Hong Kong
Hong Kong, Please Select, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019.624
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.